Cargando…

How Should Treatment Decisions Be Made for Incapacitated Patients, and Why?

Detalles Bibliográficos
Autores principales:	Shalowitz, David I, Garrett-Mayer, Elizabeth, Wendler, David
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Policy Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820603/ https://www.ncbi.nlm.nih.gov/pubmed/17388655 http://dx.doi.org/10.1371/journal.pmed.0040035

Ejemplares similares

Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?
por: Stuckler, David, et al.
Publicado: (2011)

Who Should Pay for Global Health, and How Much?
por: Carrasco, Luis R., et al.
Publicado: (2013)

How Should the Health Community Respond to Violent Political Conflict?
por: Zwi, Anthony B
Publicado: (2004)

Deception in Research on the Placebo Effect
por: Miller, Franklin G, et al.
Publicado: (2005)

Advertising in Medical Journals: Should Current Practices Change?
por: Fugh-Berman, Adriane, et al.
Publicado: (2006)

When Children Become Adults: Should Biobanks Re-Contact?
por: Giesbertz, Noor A. A., et al.
Publicado: (2016)

“Asymptomatic” Malaria: A Chronic and Debilitating Infection That Should Be Treated
por: Chen, Ingrid, et al.
Publicado: (2016)

Lessons on Ethical Decision Making from the Bioscience Industry
por: Mackie, Jocelyn E, et al.
Publicado: (2006)

An Immeasurable Crisis? A Criticism of the Millennium Development Goals and Why They Cannot Be Measured
por: Attaran, Amir
Publicado: (2005)

The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
por: Cockburn, Robert, et al.
Publicado: (2005)

A Surprising Prevention Success: Why Did the HIV Epidemic Decline in Zimbabwe?
por: Halperin, Daniel T., et al.
Publicado: (2011)

Sub-Saharan Africa's Mothers, Newborns, and Children: Where and Why Do They Die?
por: Kinney, Mary V., et al.
Publicado: (2010)

Why We Need Urban Health Equity Indicators: Integrating Science, Policy, and Community
por: Corburn, Jason, et al.
Publicado: (2012)

A Prescription for Improving Drug Formulary Decision Making
por: Schiff, Gordon D., et al.
Publicado: (2012)

Infectious disease pandemic planning and response: Incorporating decision analysis
por: Shearer, Freya M., et al.
Publicado: (2020)

Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
por: Wilkes, Michael, et al.
Publicado: (2008)

Optimal Evidence in Difficult Settings: Improving Health Interventions and Decision Making in Disasters
por: Gerdin, Martin, et al.
Publicado: (2014)

Estimating the Demand for a Preventive HIV Vaccine: Why We Need to Do Better: Reliable estimates would help in achieving several policy and advocacy objectives
por: Hecht, Robert, et al.
Publicado: (2006)

The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
por: Fugh-Berman, Adriane J.
Publicado: (2010)

How Can Journals Respond to Threats of Libel Litigation?
por: Persaud, Nav, et al.
Publicado: (2014)

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy
por: McNairy, Margaret L., et al.
Publicado: (2017)

How Can We Support the Use of Systematic Reviews in Policymaking?
por: Lavis, John N.
Publicado: (2009)

Following the Script: How Drug Reps Make Friends and Influence Doctors
por: Fugh-Berman, Adriane, et al.
Publicado: (2007)

Neglected Disease Research and Development: How Much Are We Really Spending?
por: Moran, Mary, et al.
Publicado: (2009)

How Do Courts Set Health Policy? The Case of the Colombian Constitutional Court
por: Yamin, Alicia Ely, et al.
Publicado: (2009)

Soda and Tobacco Industry Corporate Social Responsibility Campaigns: How Do They Compare?
por: Dorfman, Lori, et al.
Publicado: (2012)

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Male Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making?
Publicado: (2009)

How Do Intellectual Property Law and International Trade Agreements Affect Access to Antiretroviral Therapy?
por: Westerhaus, Michael, et al.
Publicado: (2006)

Legal Disputes over Duties to Disclose Treatment Risks to Patients: A Review of Negligence Claims and Complaints in Australia
por: Bismark, Marie M., et al.
Publicado: (2012)

Training and HIV-Treatment Scale-Up: Establishing an Implementation Research Agenda
por: McCarthy, Elizabeth A, et al.
Publicado: (2006)

Giving Legs to Restless Legs: A Case Study of How the Media Helps Make People Sick
por: Woloshin, Steven, et al.
Publicado: (2006)

Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
por: Bastian, Hilda, et al.
Publicado: (2010)

Guidance for Evidence-Informed Policies about Health Systems: Assessing How Much Confidence to Place in the Research Evidence
por: Lewin, Simon, et al.
Publicado: (2012)

Sub-Saharan Africa's Mothers, Newborns, and Children: How Many Lives Could Be Saved with Targeted Health Interventions?
por: Friberg, Ingrid K., et al.
Publicado: (2010)

How to make your research jump off the page: Co-creation to broaden public engagement in medical research
por: Finley, Nina, et al.
Publicado: (2020)

PRIME: A Programme to Reduce the Treatment Gap for Mental Disorders in Five Low- and Middle-Income Countries
por: Lund, Crick, et al.
Publicado: (2012)

The Unintended Consequences of Clinical Trials Regulations
por: McMahon, Alex D., et al.
Publicado: (2009)

Intermittent Presumptive Treatment for Malaria
por: White, Nicholas J
Publicado: (2005)

Antidepressants and Violence: Problems at the Interface of Medicine and Law
por: Healy, David, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_jdb4lui1nv9taoeae92jgdrolg